Rafferty Asset Management’s Biomea Fusion BMEA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-478,367
Closed -$7.15M 1175
2024
Q1
$7.15M Buy
478,367
+376,688
+370% +$6.2M 0.03% 376
2023
Q4
$1.48M Sell
101,679
-132,169
-57% -$1.61M 0.01% 748
2023
Q3
$3.22M Buy
233,848
+96,945
+71% +$1.75M 0.02% 485
2023
Q2
$3.01M Buy
+136,903
New +$4.29M 0.02% 528

Other funds holding BMEA

Rafferty Asset Management's BMEA Position: Q2 2024 in Review

Rafferty Asset Management sold out of Biomea Fusion (BMEA) in Q2 2024, closing a stake of 478,367 shares — an estimated $7.15M sold.

Rafferty Asset Management first reported a position in BMEA in Q2 2023 and held it in 4 quarters. The position peaked at $7.15M in Q1 2024. 107 funds tracked by Wall St. Rank hold BMEA as of Q2 2024.

  • Rafferty Asset Management reported no remaining Biomea Fusion position as of Q2 2024 after selling out during the quarter.
  • Rafferty Asset Management sold 478,367 Biomea Fusion shares in Q2 2024, an estimated $7.15M.
  • Rafferty Asset Management first reported a position in Biomea Fusion in Q2 2023 and held it in 4 quarters.
  • Rafferty Asset Management's Biomea Fusion position peaked at $7.15M in Q1 2024.
  • 107 funds tracked by Wall St. Rank held Biomea Fusion as of Q2 2024.

Based on Rafferty Asset Management's 13F filing for Q2 2024, filed 13 Aug 2024.